Michael R Wessels

Title: Michael R Wessels: Innovator in Bacterial Vaccines

Introduction

Michael R Wessels is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of immunology, particularly in the development of bacterial antigens and vaccines. His work focuses on innovative methods for manufacturing vaccines that target Group B Streptococcus.

Latest Patents

Wessels holds a patent for "Bacterial antigens, antibodies, vaccines and methods of manufacture." This patent details the creation of antigens and vaccines containing purified oligomers of the repeating pentasaccharide unit of type III Group B Streptococcus polysaccharide capsule. The methods described involve recovering polysaccharide from cultured III GBS or medium and digesting it with a specific endo-.beta.-galactosidase. The patent also covers the enzymatic cleavage of bacterial polysaccharide to produce purified oligomers, as well as a purified trypsin-resistant C surface protein with a molecular weight of about 14,000. Additionally, it discusses passive immunization using the developed vaccines and immunoassays for GBS immunodeterminants or anti-GBS antibodies.

Career Highlights

Wessels is affiliated with The Brigham and Women's Hospital, Inc., where he continues to advance research in bacterial vaccines. His innovative approaches have garnered attention in the scientific community, contributing to the understanding and prevention of bacterial infections.

Collaborations

Throughout his career, Wessels has collaborated with notable colleagues, including Dennis L Kasper and Harold J Jennings. These partnerships have enhanced the research and development of effective vaccines and immunological therapies.

Conclusion

Michael R Wessels is a key figure in the field of immunology, with a focus on developing vaccines against bacterial infections. His innovative work and collaborations have the potential to significantly impact public health.